
What We're Reading: Robotic Surgery Questioned; Migrants Quarantined; Medicaid and Sex Reassignment
Robotic surgery remains a widespread practice for cancer treatment while the FDA warns no evidence has been found linking these procedures to safer patient outcomes; more than 2000 migrants in US detention centers quarantined as reported cases of mumps arise; Iowa Supreme Court rules that Medicaid can not deny coverage for sex reassignment surgery.
FDA: No Evidence Robotic Surgery Better Than Traditional Methods for Cancer Patients
Robotic surgery has been particularly unsuccessful in treating cervical cancer as women who underwent these procedures experienced 6 times as many deaths and 4 times as many cancer recurrences than women who underwent traditional radical hysterectomy surgeries, which typically cures patients with cervical cancer. Although it lacks FDA approval, robotic surgery is being frequently used for cancer-related treatment,
More Than 2000 Migrants Quarantined as Mumps Cases Reported
Among the 50,000 migrants held in US detention centers, 2287 have been quarantined as an estimated 236 cases of mumps have been identified over the past year throughout 51 US facilities,
Iowa Supreme Court: Medicaid Can Cover Sex Reassignment Surgery
The Iowa Supreme Court recently ruled that Medicaid can provide coverage for sex reassignment surgery,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

















































